Skip to main content
. 2020 Jan 17;99(3):e18771. doi: 10.1097/MD.0000000000018771

Figure 3 (Continued).

Figure 3 (Continued)

OS, PFS or ORR for combination therapy of bevacizumab plus erlotinib with bevacizumab or erlotinib alone.